Patent · US Active

Human toll-like receptor inhibitors and methods of use thereof

US9868955B2 · kind B2 · utility

11Cited by

10References

20Claims

0Family size

Assignee

DYNAVAX TECHNOLOGIES CORPORATION · US

Inventors

Cristiana Guiducci · Albany, US
Karen L. Fearon · Lafayette, US
Franck Barrat · San Mateo, US

Key dates

Filing date	Sep 27, 2013
Grant date	Jan 16, 2018
Priority date	—
Expiry date	Jan 13, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/344
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided herein are human Toll-like receptor (TLR)-inhibitors and methods for use in individuals having an autoimmune disease or an inflammatory disorder. The TLR inhibitors of the present disclosure are polynucleotides comprising an inhibitory motif for one or more of TLR7, TLR8 and TLR9.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.